Form 8-K - Current report:
SEC Accession No. 0000950123-10-073458
Filing Date
2010-08-05
Accepted
2010-08-05 16:56:41
Documents
3
Period of Report
2010-07-30
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K c04463e8vk.htm 8-K 13545
2 EXHIBIT 99.1 c04463exv99w1.htm EX-99.1 7389
3 GRAPHIC c04463p0446301.jpg GRAPHIC 24036
  Complete submission text file 0000950123-10-073458.txt   56049
Mailing Address 20425 SENECA MEADOWS PARKWAY, GERMANTOWN, MD 20876
Business Address 20425 SENECA MEADOWS PARKWAY GERMANTOWN MD 20878 (301) 944-6600
MiddleBrook Pharmaceuticals, Inc. (Filer) CIK: 0001161924 (see all company filings)

EIN.: 522208264 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50414 | Film No.: 10995186
SIC: 2834 Pharmaceutical Preparations